VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,308,040 | -19.3% | 215,648 | +25.2% | 0.00% | 0.0% |
Q2 2023 | $4,098,993 | +29.5% | 172,299 | +38.5% | 0.00% | 0.0% |
Q1 2023 | $3,164,635 | -10.1% | 124,396 | +3.2% | 0.00% | 0.0% |
Q4 2022 | $3,519,892 | -66.7% | 120,503 | -79.2% | 0.00% | -50.0% |
Q2 2021 | $10,582,000 | +9.5% | 578,560 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $9,668,000 | – | 578,560 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |